Home Healthcare Healthcare Services Cancer Immunotherapy Drug Discovery Outsourcing Market

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Service Type (Target Identification and Validation, Lead Screening and Characterization, Cell-based Assays), By Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic, Othe Types), By Drug Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Viral Therapy, Other Drug Types) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 21, 2026 | Author: Debashree B | Format: | Report Code: SR2676DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Cancer Immunotherapy Drug Discovery Outsourcing Market Size Analysis
    1. Introduction
    2. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Target Identification and Validation
      2. Lead Screening and Characterization
      3. Cell-based Assays
    3. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Breast
      3. Colorectal
      4. Melanoma
      5. Prostate
      6. Head and Neck
      7. Ovarian
      8. Pancreatic
      9. Othe Types
    4. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Immunomodulators
      3. Cancer Vaccines and Oncolytic Viral Therapy
      4. Other Drug Types
  7. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Analysis
    1. Introduction
    2. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Target Identification and Validation
      2. Lead Screening and Characterization
      3. Cell-based Assays
    3. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Breast
      3. Colorectal
      4. Melanoma
      5. Prostate
      6. Head and Neck
      7. Ovarian
      8. Pancreatic
      9. Othe Types
    4. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Immunomodulators
      3. Cancer Vaccines and Oncolytic Viral Therapy
      4. Other Drug Types
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
  8. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Analysis
    1. Introduction
    2. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Target Identification and Validation
      2. Lead Screening and Characterization
      3. Cell-based Assays
    3. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Breast
      3. Colorectal
      4. Melanoma
      5. Prostate
      6. Head and Neck
      7. Ovarian
      8. Pancreatic
      9. Othe Types
    4. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Immunomodulators
      3. Cancer Vaccines and Oncolytic Viral Therapy
      4. Other Drug Types
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    7. France
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
  9. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Analysis
    1. Introduction
    2. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Target Identification and Validation
      2. Lead Screening and Characterization
      3. Cell-based Assays
    3. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Breast
      3. Colorectal
      4. Melanoma
      5. Prostate
      6. Head and Neck
      7. Ovarian
      8. Pancreatic
      9. Othe Types
    4. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Immunomodulators
      3. Cancer Vaccines and Oncolytic Viral Therapy
      4. Other Drug Types
    5. China
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    8. India
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
  10. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Analysis
    1. Introduction
    2. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Target Identification and Validation
      2. Lead Screening and Characterization
      3. Cell-based Assays
    3. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Breast
      3. Colorectal
      4. Melanoma
      5. Prostate
      6. Head and Neck
      7. Ovarian
      8. Pancreatic
      9. Othe Types
    4. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Immunomodulators
      3. Cancer Vaccines and Oncolytic Viral Therapy
      4. Other Drug Types
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
  11. LATAM Cancer Immunotherapy Drug Discovery Outsourcing Market Size Analysis
    1. Introduction
    2. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Target Identification and Validation
      2. Lead Screening and Characterization
      3. Cell-based Assays
    3. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Breast
      3. Colorectal
      4. Melanoma
      5. Prostate
      6. Head and Neck
      7. Ovarian
      8. Pancreatic
      9. Othe Types
    4. Cancer Immunotherapy Drug Discovery Outsourcing Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Immunomodulators
      3. Cancer Vaccines and Oncolytic Viral Therapy
      4. Other Drug Types
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Target Identification and Validation
        2. Lead Screening and Characterization
        3. Cell-based Assays
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Breast
        3. Colorectal
        4. Melanoma
        5. Prostate
        6. Head and Neck
        7. Ovarian
        8. Pancreatic
        9. Othe Types
      4. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Immunomodulators
        3. Cancer Vaccines and Oncolytic Viral Therapy
        4. Other Drug Types
  12. Competitive Landscape
    1. Cancer Immunotherapy Drug Discovery Outsourcing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Covance Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Crown Bioscience Inc.
    3. Horizon Discovery Group plc
    4. GenScript Biotech Corporation
    5. BPS Bioscience Inc.
    6. HD Biosciences Co. Ltd.
    7. Promega Corporation
    8. DiscoverX Corporation
    9. Explicyte
    10. ImmunXperts SA
    11. Celentyx Ltd.
    12. Aquila BioMedical
    13. STC Biologics
    14. Personalis Inc.
    15. Molecular Imaging Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.